Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone.
D000818:Animals; D003520:Cyclophosphamide / Q000009:adverse effects*; D004195:Disease Models, Animal; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006065:Gonadotropins, Pituitary / Q000378:metabolism; D006801:Humans; D016729:Leuprolide; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D012636:Secretory Rate / Q000187:drug effects; D013091:Spermatogenesis / Q000187:drug effects*; D013093:Spermatogonia / Q000187:drug effects; D013736:Testicular Neoplasms / Q000139:chemically induced / Q000517:prevention & control*
D006065:Gonadotropins, Pituitary; D007987:Gonadotropin-Releasing Hormone; D003520:Cyclophosphamide; D016729:Leuprolide